» Authors » Carlos Rojano-Alfonso

Carlos Rojano-Alfonso

Explore the profile of Carlos Rojano-Alfonso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 38
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mico-Carnero M, Rojano-Alfonso C, Maroto-Serrat C, Cutrin J, Casillas-Ramirez A, Peralta C
Front Cell Dev Biol . 2025 Jan; 12():1455258. PMID: 39839674
Introduction: Grafts with alcohol-associated liver disease (ALD) subjected to prolonged cold ischaemia from donors after brain death (DBD) are typically unsuitable for transplantation. Here, we investigated the role of growth...
2.
Casillas-Ramirez A, Maroto-Serrat C, Sanus F, Mico-Carnero M, Rojano-Alfonso C, Cabrer M, et al.
Am J Pathol . 2024 Nov; 195(3):494-527. PMID: 39566822
The donor shortage increases liver transplantation (LT) waiting lists, making it crucial to consider extended-criteria donors, such as steatotic donors after brain death (DBDs) or cardiocirculatory death (DCDs). Nevertheless, steatosis,...
3.
Mico-Carnero M, Zaouali M, Rojano-Alfonso C, Maroto-Serrat C, Ben Abdennebi H, Peralta C
Cells . 2022 Sep; 11(17). PMID: 36078175
The pathophysiological process of ischemia and reperfusion injury (IRI), an inevitable step in organ transplantation, causes important biochemical and structural changes that can result in serious organ damage. IRI is...
4.
Mico-Carnero M, Casillas-Ramirez A, Sanchez-Gonzalez A, Rojano-Alfonso C, Peralta C
Biomedicines . 2022 May; 10(5). PMID: 35625715
Background: Brain death (BD) and steatosis are key risk factors to predict adverse post-transplant outcomes. We investigated the role of Neuregulin-1 (NRG1) in rat steatotic and non-steatotic liver transplantation (LT)...
5.
Alvarez-Mercado A, Caballeria-Casals A, Rojano-Alfonso C, Chavez-Reyes J, Mico-Carnero M, Sanchez-Gonzalez A, et al.
Biomedicines . 2021 Sep; 9(9). PMID: 34572344
Hepatocellular carcinoma has become a leading cause of cancer-associated mortality throughout the world, and is of great concern. Currently used chemotherapeutic drugs in the treatment of hepatocellular carcinoma lead to...
6.
Mico-Carnero M, Casillas-Ramirez A, Caballeria-Casals A, Rojano-Alfonso C, Sanchez-Gonzalez A, Peralta C
Nutrients . 2021 Aug; 13(8). PMID: 34444713
Herein, we investigate whether: (1) the administration of glucose or a lipid emulsion is useful in liver transplantation (LT) using steatotic (induced genetically or nutritionally) or non-steatotic livers from donors...
7.
Caballeria-Casals A, Mico-Carnero M, Rojano-Alfonso C, Maroto-Serrat C, Casillas-Ramirez A, Alvarez-Mercado A, et al.
Cells . 2021 Jul; 10(6). PMID: 34200439
The pro-tumorigenic activity of fibroblast growth factor (FGF) 19 (FGF15 in its rodent orthologue) in hepatocellular carcinoma (HCC), as well as the unsolved problem that ischemia-reperfusion (IR) injury supposes in...
8.
Isabel Alvarez-Mercado A, Rojano-Alfonso C, Mico-Carnero M, Caballeria-Casals A, Peralta C, Casillas-Ramirez A
Front Cell Dev Biol . 2021 Jun; 9:670273. PMID: 34141709
Visceral obesity is an important component of metabolic syndrome, a cluster of diseases that also includes diabetes and insulin resistance. A combination of these metabolic disorders damages liver function, which...
9.
Mico-Carnero M, Rojano-Alfonso C, Isabel Alvarez-Mercado A, Gracia-Sancho J, Casillas-Ramirez A, Peralta C
Int J Mol Sci . 2020 Dec; 22(1). PMID: 33375200
Microbiota is defined as the collection of microorganisms within the gastrointestinal ecosystem. These microbes are strongly implicated in the stimulation of immune responses. An unbalanced microbiota, termed dysbiosis, is related...